Creative Medical Technology to Participate in the 34th Annual Roth Conference
Creative Medical Technology Holdings (NASDAQ: CELZ) announced its participation in the 34th Annual Roth Conference from March 13-15, 2022, in Dana Point, California.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Creative Medical Technology Holdings (NASDAQ: CELZ) announced its participation in the 34th Annual Roth Conference from March 13-15, 2022, in Dana Point, California. The company specializes in regenerative approaches in immunotherapy, urology, neurology, and orthopedics. Executives will be available for one-on-one meetings during the event. For more details or to register, visit the conference's registration page. The latest investor presentation can be found on the company's IR website.
Details
News Market Reaction – CELZ
The recorded move for CELZ in the trading session of this news was -10.74%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PHOENIX, March 8, 2022 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that Company executives will be participating in the 34th Annual Roth Conference to be held March 13-15, 2022 in Dana Point, California. Management will be available for one-on-one meetings throughout the conference.
To learn more about the conference and submit a registration request, please visit:
https://ibn.fm/ROTH2022Registration.
A copy of the Company's latest investor presentation, which will be used during one-on-one meetings, can be found on Creative Medical Technology's IR website at: https://creativemedicaltechnology.investorroom.com/.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company specializing in stem cell technology in the fields of immunotherapy, urology, neurology, and orthopedics. For further information about the company, please visit www.creativemedicaltechnology.com.
About Roth Capital Partners
Roth Capital Partners, LLC ("Roth") is a relationship-driven investment bank focused on serving emerging growth companies and their investors. As a full-service investment bank, Roth provides capital raising, M&A advisory, analytical research, trading, market-making services, and corporate access. Headquartered in Newport Beach, California, Roth is privately held and owned by its employees and maintains offices throughout the U.S. For more information on Roth, please visit www.roth.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/creative-medical-technology-to-participate-in-the-34th-annual-roth-conference-301496930.html
SOURCE Creative Medical Technology Holdings, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.